+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Artificial Organ And Bionics Market Size, Share & Industry Trends Analysis Report By Product (Artificial Organs and Artificial Bionics), By Technology (Mechanical and Electronic), By Regional Outlook and Forecast, 2022-2028

  • PDF Icon

    Report

  • 255 Pages
  • June 2022
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5636655
The Global Artificial Organ And Bionics Market size is expected to reach $39.5 billion by 2028, rising at a market growth of 9.8% CAGR during the forecast period.

Blood loss, substance addiction, severe trauma, and other severe disorders are the main causes of organ failure. Additionally, unhealthy lifestyle activities, like smoking, drinking too much alcohol, eating poorly, and not engaging in physical activities have a significant impact on organ function. Additionally, it is anticipated that the availability of cutting-edge artificial support systems and advancements in healthcare facilities is expected to increase the demand for bionics and artificial organs. Because 3D bioprinting is utilized to create artificial organs, it is significantly essential for the artificial organ and bionic transplantation industry.



Since it reduces the possibility of organ rejection, 3D bioprinting is becoming increasingly popular. The global trends for artificial gadgets are also about to change as a result of the advent of artificial intelligence. Many countries are currently focusing on the development of a tool that offers a personalized assessment of organs along with donor suitability. This tool will be very useful in helping patients decide whether to accept donor organs or wait for better possibilities when making decisions regarding organ retrieval.

Artificial limbs known as bionic limbs use impulses from the patient's muscles to move naturally. In order to generate the correct movements, certain bionic limbs also depend on electrical inputs from the brain and nerves. These limbs, like bionic hands, can be mechanically or electronically propelled. Some bionic limb alternatives use a mix of the two. Bionic limbs offer significantly more support and functionality than conventional prosthetic limbs since they are powered by both muscles as well as the brain in addition to the body.

Artificial intelligence and machine learning could support a patient's transition through heart transplantation by analyzing initial lab tests and imaging to predict the potential benefits of transplantation, determining graft failure or mortality after transplantation, helping a patient stick to their medication regimen, and inducing healthy behavioral changes to reduce future cardiovascular risk.

COVID-19 Impact Analysis

The artificial organ and bionics markets were also negatively impacted by the COVID-19 pandemic. The pandemic posed additional difficulties for those with disabilities and organ failures. In order to overcome the limits on market expansion caused by social distance, numerous medical facilities provided video conferencing to patients with disabilities instead of non-elective procedures and surgeries. The market was also impeded by therapeutic restrictions. Additionally, a significant number of people have been impacted by the coronavirus pandemic, which has led to a high number of fatalities, a heavy disease burden, as well as financial instability. The enormous surge of patients put the hospital infrastructure and system under tremendous strain.

Market Growth Factors


Improved mobility and quality of life

When compared to a socket prosthesis, an Osseo-integrated prosthesis has many benefits for people who have lost an arm or a leg. For example, walking can become much easier with the Osseo-integrated prosthesis connection, which is significantly more stable and offers a full range of joint movement. When worn, an Osseo-integrated prosthesis doesn't hurt or damage the skin. As a result of the prosthesis' direct attachment to the bone, a phenomenon known as natural Osseo-perception occurs in which the patient asserts their prosthesis to be a part of their own body. This is an incredibly novel method, which significantly enhances the quality of life for those who have had an amputation, and has been made available by a significant number of artificial organs and bionics manufacturers all over the world in recent years.

An increasing number of R&D activities along with government support

Patients are encouraged by the robust potential of bionic limbs to change their lives via long-term efficacy studies. The prosthesis can be directly attached to an implant that has undergone osseointegration, which has immediate advantages. It makes it simpler to connect and remove the prosthesis. Additionally, it offers a considerably more comfortable sitting position and enables much greater movement. There is a considerable number of R&D activities stating that Osseo-integrated implants connected to bionic limbs greatly enhance movement. For young people, this is especially clear. They can really detect more vibrations. This aids in detecting the type of surface being walked on as well as the location of the prosthetic foot on the ground.

Marketing Restraining Factor:


Requirement for immense care after the transplant

It is challenging to create prosthetic fittings that permit sustained high levels of daily activities. In fact, edema, neuromas, muscular contractures, fractures, and acute and chronic skin conditions can all threaten the skin, nerves, muscles, and bones of the residuum (also known as the stump). This makes it challenging to handle everyday prosthesis loading. Additionally, it can be difficult to fit sockets around stumps with odd forms. Patients who live in warmer climates are particularly harmed since sweating from the heat and humidity makes it difficult to wear sockets. In a lot of instances, difficulties with prosthetic fits result in frequent and, too frequently, permanent prosthesis abandonment.



Product Outlook

Based on Product, the market is segmented into Artificial Organs (Kidney, Heart, Lungs, Liver, and Pancreas) and Artificial Bionics (Cochlear Implant, Bionic limbs, Exoskeleton, Vision bionics, and Brain bionics). In 2021, the Artificial Bionics segment recorded a significant revenue share of the artificial organs and bionics market. The growing need for cochlear implants, exoskeletons, vision, limbs, and brain bionics are the main drivers of the growth of the segment. The artificial organs and bionics market is also booming as a result of advantageous reimbursement policies and increasing FDA approval for implants.

Technology Outlook

Based on Technology, the market is segmented into Mechanical and Electronic. In 2021, the mechanical bionics segment procured the highest revenue share of the artificial organs and bionics market. The prevalence of organ failure is increasing, and mechanical bionics are becoming more affordable. Since a mechanical artificial heart valve lasts significantly longer than the alternatives, there is a high demand for them. Rapid FDA approvals, as well as reimbursement policies, are further factors promoting expansion.

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. In 2021, North America accounted for the largest revenue share of the artificial organs and bionics market. The demand for artificial organs due to the increased prevalence of organ failure and the rise in transplant surgery are the major factors that are aiding in the growth of the regional market. In addition, the development in the field of organs and bionics transplant is further aided by the availability of sophisticated healthcare facilities and a large number of local branches of well-known biotechnology and medical device businesses.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abiomed, Inc., Berlin Heart GmbH, Zimmer Biomet Holdings, Inc., Boston Scientific Corporation, Cochlear Ltd., Ekso Bionics Holdings, Inc., Jarvik Heart, Inc., Medtronic PLC, iWALKFree, Inc., and Edwards Lifesciences Corporation.

Scope of the Study


Market Segments Covered in the Report:


By Product
  • Artificial Organs
  • Kidney
  • Heart
  • Lungs
  • Liver
  • Pancreas
  • Artificial Bionics
  • Cochlear Implant
  • Bionic limbs
  • Exoskeleton
  • Vision bionics
  • Brain bionics
By Technology
  • Mechanical
  • Electronic
By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players


List of Companies Profiled in the Report:

  • Abiomed, Inc.
  • Berlin Heart GmbH
  • Zimmer Biomet Holdings, Inc.
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • Ekso Bionics Holdings, Inc.
  • Jarvik Heart, Inc.
  • Medtronic PLC
  • iWALKFree, Inc.
  • Edwards Lifesciences Corporation

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Artificial Organ And Bionics Market, by Product
1.4.2 Global Artificial Organ And Bionics Market, by Technology
1.4.3 Global Artificial Organ And Bionics Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Artificial Organ And Bionics Market by Product
3.1 Global Artificial Organs Market by Region
3.2 Global Artificial Organ And Bionics Market by Artificial Organs Type
3.2.1 Global Kidney Market by Region
3.2.2 Global Heart Market by Region
3.2.3 Global Lungs Market by Region
3.2.4 Global Liver Market by Region
3.2.5 Global Pancreas Market by Region
3.3 Global Artificial Bionics Market by Region
3.4 Global Artificial Organ And Bionics Market by Artificial Bionics Type
3.4.1 Global Cochlear Implant Market by Region
3.4.2 Global Bionic limbs Market by Region
3.4.3 Global Exoskeleton Market by Region
3.4.4 Global Vision bionics Market by Region
3.4.5 Global Brain bionics Market by Region
Chapter 4. Global Artificial Organ And Bionics Market by Technology
4.1 Global Mechanical Market by Region
4.2 Global Electronic Market by Region
Chapter 5. Global Artificial Organ And Bionics Market by Region
5.1 North America Artificial Organ And Bionics Market
5.1.1 North America Artificial Organ And Bionics Market by Product
5.1.1.1 North America Artificial Organs Market by Country
5.1.1.2 North America Artificial Organ And Bionics Market by Artificial Organs Type
5.1.1.2.1 North America Kidney Market by Country
5.1.1.2.2 North America Heart Market by Country
5.1.1.2.3 North America Lungs Market by Country
5.1.1.2.4 North America Liver Market by Country
5.1.1.2.5 North America Pancreas Market by Country
5.1.1.3 North America Artificial Bionics Market by Country
5.1.1.4 North America Artificial Organ And Bionics Market by Artificial Bionics Type
5.1.1.4.1 North America Cochlear Implant Market by Country
5.1.1.4.2 North America Bionic limbs Market by Country
5.1.1.4.3 North America Exoskeleton Market by Country
5.1.1.4.4 North America Vision bionics Market by Country
5.1.1.4.5 North America Brain bionics Market by Country
5.1.2 North America Artificial Organ And Bionics Market by Technology
5.1.2.1 North America Mechanical Market by Country
5.1.2.2 North America Electronic Market by Country
5.1.3 North America Artificial Organ And Bionics Market by Country
5.1.3.1 US Artificial Organ And Bionics Market
5.1.3.1.1 US Artificial Organ And Bionics Market by Product
5.1.3.1.2 US Artificial Organ And Bionics Market by Technology
5.1.3.2 Canada Artificial Organ And Bionics Market
5.1.3.2.1 Canada Artificial Organ And Bionics Market by Product
5.1.3.2.2 Canada Artificial Organ And Bionics Market by Technology
5.1.3.3 Mexico Artificial Organ And Bionics Market
5.1.3.3.1 Mexico Artificial Organ And Bionics Market by Product
5.1.3.3.2 Mexico Artificial Organ And Bionics Market by Technology
5.1.3.4 Rest of North America Artificial Organ And Bionics Market
5.1.3.4.1 Rest of North America Artificial Organ And Bionics Market by Product
5.1.3.4.2 Rest of North America Artificial Organ And Bionics Market by Technology
5.2 Europe Artificial Organ And Bionics Market
5.2.1 Europe Artificial Organ And Bionics Market by Product
5.2.1.1 Europe Artificial Organs Market by Country
5.2.1.2 Europe Artificial Organ And Bionics Market by Artificial Organs Type
5.2.1.2.1 Europe Kidney Market by Country
5.2.1.2.2 Europe Heart Market by Country
5.2.1.2.3 Europe Lungs Market by Country
5.2.1.2.4 Europe Liver Market by Country
5.2.1.2.5 Europe Pancreas Market by Country
5.2.1.3 Europe Artificial Bionics Market by Country
5.2.1.4 Europe Artificial Organ And Bionics Market by Artificial Bionics Type
5.2.1.4.1 Europe Cochlear Implant Market by Country
5.2.1.4.2 Europe Bionic limbs Market by Country
5.2.1.4.3 Europe Exoskeleton Market by Country
5.2.1.4.4 Europe Vision bionics Market by Country
5.2.1.4.5 Europe Brain bionics Market by Country
5.2.2 Europe Artificial Organ And Bionics Market by Technology
5.2.2.1 Europe Mechanical Market by Country
5.2.2.2 Europe Electronic Market by Country
5.2.3 Europe Artificial Organ And Bionics Market by Country
5.2.3.1 Germany Artificial Organ And Bionics Market
5.2.3.1.1 Germany Artificial Organ And Bionics Market by Product
5.2.3.1.2 Germany Artificial Organ And Bionics Market by Technology
5.2.3.2 UK Artificial Organ And Bionics Market
5.2.3.2.1 UK Artificial Organ And Bionics Market by Product
5.2.3.2.2 UK Artificial Organ And Bionics Market by Technology
5.2.3.3 France Artificial Organ And Bionics Market
5.2.3.3.1 France Artificial Organ And Bionics Market by Product
5.2.3.3.2 France Artificial Organ And Bionics Market by Technology
5.2.3.4 Russia Artificial Organ And Bionics Market
5.2.3.4.1 Russia Artificial Organ And Bionics Market by Product
5.2.3.4.2 Russia Artificial Organ And Bionics Market by Technology
5.2.3.5 Spain Artificial Organ And Bionics Market
5.2.3.5.1 Spain Artificial Organ And Bionics Market by Product
5.2.3.5.2 Spain Artificial Organ And Bionics Market by Technology
5.2.3.6 Italy Artificial Organ And Bionics Market
5.2.3.6.1 Italy Artificial Organ And Bionics Market by Product
5.2.3.6.2 Italy Artificial Organ And Bionics Market by Technology
5.2.3.7 Rest of Europe Artificial Organ And Bionics Market
5.2.3.7.1 Rest of Europe Artificial Organ And Bionics Market by Product
5.2.3.7.2 Rest of Europe Artificial Organ And Bionics Market by Technology
5.3 Asia Pacific Artificial Organ And Bionics Market
5.3.1 Asia Pacific Artificial Organ And Bionics Market by Product
5.3.1.1 Asia Pacific Artificial Organs Market by Country
5.3.1.2 Asia Pacific Artificial Organ And Bionics Market by Artificial Organs Type
5.3.1.2.1 Asia Pacific Kidney Market by Country
5.3.1.2.2 Asia Pacific Heart Market by Country
5.3.1.2.3 Asia Pacific Lungs Market by Country
5.3.1.2.4 Asia Pacific Liver Market by Country
5.3.1.2.5 Asia Pacific Pancreas Market by Country
5.3.1.3 Asia Pacific Artificial Bionics Market by Country
5.3.1.4 Asia Pacific Artificial Organ And Bionics Market by Artificial Bionics Type
5.3.1.4.1 Asia Pacific Cochlear Implant Market by Country
5.3.1.4.2 Asia Pacific Bionic limbs Market by Country
5.3.1.4.3 Asia Pacific Exoskeleton Market by Country
5.3.1.4.4 Asia Pacific Vision bionics Market by Country
5.3.1.4.5 Asia Pacific Brain bionics Market by Country
5.3.2 Asia Pacific Artificial Organ And Bionics Market by Technology
5.3.2.1 Asia Pacific Mechanical Market by Country
5.3.2.2 Asia Pacific Electronic Market by Country
5.3.3 Asia Pacific Artificial Organ And Bionics Market by Country
5.3.3.1 China Artificial Organ And Bionics Market
5.3.3.1.1 China Artificial Organ And Bionics Market by Product
5.3.3.1.2 China Artificial Organ And Bionics Market by Technology
5.3.3.2 Japan Artificial Organ And Bionics Market
5.3.3.2.1 Japan Artificial Organ And Bionics Market by Product
5.3.3.2.2 Japan Artificial Organ And Bionics Market by Technology
5.3.3.3 India Artificial Organ And Bionics Market
5.3.3.3.1 India Artificial Organ And Bionics Market by Product
5.3.3.3.2 India Artificial Organ And Bionics Market by Technology
5.3.3.4 South Korea Artificial Organ And Bionics Market
5.3.3.4.1 South Korea Artificial Organ And Bionics Market by Product
5.3.3.4.2 South Korea Artificial Organ And Bionics Market by Technology
5.3.3.5 Singapore Artificial Organ And Bionics Market
5.3.3.5.1 Singapore Artificial Organ And Bionics Market by Product
5.3.3.5.2 Singapore Artificial Organ And Bionics Market by Technology
5.3.3.6 Malaysia Artificial Organ And Bionics Market
5.3.3.6.1 Malaysia Artificial Organ And Bionics Market by Product
5.3.3.6.2 Malaysia Artificial Organ And Bionics Market by Technology
5.3.3.7 Rest of Asia Pacific Artificial Organ And Bionics Market
5.3.3.7.1 Rest of Asia Pacific Artificial Organ And Bionics Market by Product
5.3.3.7.2 Rest of Asia Pacific Artificial Organ And Bionics Market by Technology
5.4 LAMEA Artificial Organ And Bionics Market
5.4.1 LAMEA Artificial Organ And Bionics Market by Product
5.4.1.1 LAMEA Artificial Organs Market by Country
5.4.1.2 LAMEA Artificial Organ And Bionics Market by Artificial Organs Type
5.4.1.2.1 LAMEA Kidney Market by Country
5.4.1.2.2 LAMEA Heart Market by Country
5.4.1.2.3 LAMEA Lungs Market by Country
5.4.1.2.4 LAMEA Liver Market by Country
5.4.1.2.5 LAMEA Pancreas Market by Country
5.4.1.3 LAMEA Artificial Bionics Market by Country
5.4.1.4 LAMEA Artificial Organ And Bionics Market by Artificial Bionics Type
5.4.1.4.1 LAMEA Cochlear Implant Market by Country
5.4.1.4.2 LAMEA Bionic limbs Market by Country
5.4.1.4.3 LAMEA Exoskeleton Market by Country
5.4.1.4.4 LAMEA Vision bionics Market by Country
5.4.1.4.5 LAMEA Brain bionics Market by Country
5.4.2 LAMEA Artificial Organ And Bionics Market by Technology
5.4.2.1 LAMEA Mechanical Market by Country
5.4.2.2 LAMEA Electronic Market by Country
5.4.3 LAMEA Artificial Organ And Bionics Market by Country
5.4.3.1 Brazil Artificial Organ And Bionics Market
5.4.3.1.1 Brazil Artificial Organ And Bionics Market by Product
5.4.3.1.2 Brazil Artificial Organ And Bionics Market by Technology
5.4.3.2 Argentina Artificial Organ And Bionics Market
5.4.3.2.1 Argentina Artificial Organ And Bionics Market by Product
5.4.3.2.2 Argentina Artificial Organ And Bionics Market by Technology
5.4.3.3 UAE Artificial Organ And Bionics Market
5.4.3.3.1 UAE Artificial Organ And Bionics Market by Product
5.4.3.3.2 UAE Artificial Organ And Bionics Market by Technology
5.4.3.4 Saudi Arabia Artificial Organ And Bionics Market
5.4.3.4.1 Saudi Arabia Artificial Organ And Bionics Market by Product
5.4.3.4.2 Saudi Arabia Artificial Organ And Bionics Market by Technology
5.4.3.5 South Africa Artificial Organ And Bionics Market
5.4.3.5.1 South Africa Artificial Organ And Bionics Market by Product
5.4.3.5.2 South Africa Artificial Organ And Bionics Market by Technology
5.4.3.6 Nigeria Artificial Organ And Bionics Market
5.4.3.6.1 Nigeria Artificial Organ And Bionics Market by Product
5.4.3.6.2 Nigeria Artificial Organ And Bionics Market by Technology
5.4.3.7 Rest of LAMEA Artificial Organ And Bionics Market
5.4.3.7.1 Rest of LAMEA Artificial Organ And Bionics Market by Product
5.4.3.7.2 Rest of LAMEA Artificial Organ And Bionics Market by Technology
Chapter 6. Company Profiles
6.1 Medtronic PLC
6.1.1 Company overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expenses
6.2 Boston Scientific Corporation
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 SWOT Analysis
6.3 Abiomed, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional Analysis
6.3.4 Research & Development Expenses
6.4 Berlin Heart GmbH
6.4.1 Company Overview
6.5 Jarvik Heart, Inc.
6.5.1 Company Overview
6.6 Zimmer Biomet Holdings, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Cochlear Ltd.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Research & Development Expense
6.8 Ekso Bionics Holdings, Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expenses
6.9 iWALKFree, Inc.
6.9.1 Company Overview
6.10. Edwards Lifesciences Corporation
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Regional Analysis
6.10.4 Research & Development Expenses

Companies Mentioned

  • Abiomed, Inc.
  • Berlin Heart GmbH
  • Zimmer Biomet Holdings, Inc.
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • Ekso Bionics Holdings, Inc.
  • Jarvik Heart, Inc.
  • Medtronic PLC
  • iWALKFree, Inc.
  • Edwards Lifesciences Corporation

Methodology

Loading
LOADING...